| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |